Quadruple therapy useful for treating persons afflicted with the human immunodeficiency virus (HIV)
US9101633B2 · kind B2 · utility
1Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 19, 2010 |
| Grant date | Aug 11, 2015 |
| Priority date | — |
| Expiry date | May 26, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition for treating the human immunodeficiency virus (HIV) in a human being, comprising four active principles selected as being:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.